Loading...
You are here:  Home  >  Health  >  Current News

New test may turn AZ’s Lynparza into precision drug for prostate cancer



LONDON (Reuters) - Scientists have developed a new three-in-one blood test that has the potential to turn AstraZeneca's drug Lynparza into a precision medicine for prostate cancer.


Other News

Gilead challenges GSK with strong HIV drug data LONDON (Reuters) - Gilead Sciences has thrown down a challenge to GlaxoSmithKline with good clinical trial results for an experimental HIV drug that...
Film to help families prevent LGBT youth suicides (Reuters Health) - When families reject their lesbian, gay, bisexual or transgender (LGBT) children, it dramatically increases the youths' risk for ...
Illicit drugs? How Brexit risks legal limbo for medicines LONDON (Reuters) - A British vote to leave the European Union would threaten some prescription medicines with regulatory limbo, posing a legal heada...

Found news:

Loading...

You might also like...

Novartis receives EU approval for breast cancer drug Kisqali

Read More →